ArticleFrontiers in surgery2025
Analysis of the diagnostic value of peripheral blood immune inflammatory indicators of female bladder pain syndrome.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and hypothesis: Female bladder pain syndrome (FBPS), previously known as interstitial cystitis/bladder pain syndrome (IC/BPS). Numerous research indirectly prove that Female bladder pain syndrome (FBPS) is associated with immune-related inflammation. According to the correlation analysis between peripheral blood immune-inflammatory markers and disease diagnosis, this research further verifies the potential diagnostic value of peripheral blood inflammatory markers in FBPS. Method: A total of 149 women with bladder pain syndrome who visited the urology department of our hospital from January 2013 to December 2024 and 149 healthy controls Patients who underwent health examinations at the physical examination center of our hospital from January 2022 to January 2023 were screened. All patients' peripheral blood inflammatory markers at admission included Neutrophil-to-Lymphocyte ratio (NLR), Systemic Immune Inflammation index (SII), et al. The maximum bladder capacity (MBC) during surgery served as the bladder volume. Multivariate binary regression was used to calculate the correlation between these indicators and disease diagnosis as well as MBC. The correlation between these indicators and MBC is secondary outcomes. The optimal cut-off value for the parameters was identified using the receiver operating characteristic (ROC) curve and its area under the curve (AUC) over time. Results: Compared with the control group, patients in the observation group demonstrated significantly higher SII, NLR, PLR, neutrophil count, whereas peripheral blood platelet count (PLT) and absolute lymphocyte count decreased, with statistically significant differences (all Conclusion: Peripheral blood inflammation indicators can be employed as an auxiliary diagnostic standard for FPBS, and NLR can be used as an independent diagnostic indicator for FBPS. However, further prospective studies are warranted to identify the causal relationship of these indicators with patient symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.